Peptide Hubs
Latest laboratory result 30.39 mg/vial January 12, 2026 · 151.95% of 20 mg label claim · Batch #GACH012 View
You will save $18.00
Chonluten 20 mg
Product Details Peptide Hubs
Active Substance Chonluten Short peptide bioregulator
Strength 20 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Peptide bioregulator
Research Focus Respiratory tissue Bronchial epithelium research
Human Half-Life Not established
Development Status Investigational
$27.00
$45.00
Shipping Location :
International
U.S. Domestic
Chonluten 20 mg – Peptide Hubs
Chonluten is a synthetic short-chain peptide developed for use in respiratory and immune system research. Derived from bronchial mucosa regulatory peptides, Chonluten is designed to support tissue regeneration, modulate local immune responses, and reduce inflammation within the lungs and airways. The 20 mg lyophilized format from Peptide Hubs offers researchers a stable, high-purity tool for experimental use in pulmonary and immune health studies.
What Is Chonluten?
Chonluten belongs to the peptide bioregulator family and has been studied in models of chronic obstructive pulmonary disease (COPD), bronchitis, asthma, allergic inflammation, and post-viral lung repair. It supports the normalization of bronchial epithelium function and has shown promise in balancing cytokine profiles and reducing inflammation markers in preclinical testing.
Mechanism of Action
Chonluten functions at the epigenetic level by influencing DNA transcription processes in cells of the bronchial mucosa. It supports the restoration of cellular function, reduces chronic inflammation, and promotes immunological stability. For further scientific reference, see this NIH publication on short peptides and tissue regulation.
Technical Details
Peptide Type
Synthetic Linear Tripeptide
Peptide Sequence
Glu-Asp-Gly (EDG)
Peptide Length
3 Amino-Acid Residues
Terminal Form
H-Glu-Asp-Gly-OH
Sequence Code
EDG
Molecular Formula
C₁₁H₁₇N₃O₈
Molecular Weight
319.27 g/mol
Research Status
Experimental
Dosage & Usage Guidelines
Chonluten is primarily used in studies focusing on:
- Respiratory tract recovery post-infection
- Immune system modulation during chronic inflammation
- Support in bronchial epithelium regeneration
- Experimental asthma and COPD models
In some advanced respiratory recovery protocols, researchers stack Chonluten with Bronchogen 20 mg for enhanced pulmonary effects, or with ARA-290 to control inflammation while supporting vascular repair.
Suggested Experimental Use
- Dose: 10–20 mg per day
- Route: Subcutaneous or intranasal administration depending on the study
- Cycle Length: 10–20 days, based on the respiratory model
Peptide Stacking Options
Chonluten is often combined with other peptides for synergistic support in respiratory and systemic recovery:
- Semax – for neuro-immunomodulatory effects
- Cartalax – to aid connective tissue recovery in thoracic structures
- B7-33 – for anti-fibrotic effects in pulmonary studies
Safety and Legality
Chonluten has shown a strong safety profile in non-human models. It is non-hormonal, non-androgenic, and does not interfere with the endocrine system, blood pressure, or liver enzymes. Like all Peptide Hubs products, Chonluten 20 mg is sold exclusively for laboratory and research use and is not approved for human consumption.
Regulatory Notes
To stay updated on peptide bioregulator research and regulatory status, consult the ClinicalTrials.gov database.
Batch-Tested & Verified Lab Results
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery
This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
What to Expect
- ✔ Orders are processed after payment confirmation
- ✔ USA Domestic shipping is typically faster when local stock is selected
- ✔ International orders include tracking, though update frequency may vary by destination
- ✔ Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Frequently Asked Questions
What is Chonluten used for?
Chonluten is a peptide bioregulator used in respiratory research to study inflammation reduction, immune modulation, and epithelial repair in the lungs.
Is Chonluten effective for asthma models?
Yes, Chonluten has been studied in models of asthma and bronchial inflammation for its immunomodulatory and tissue-stabilizing effects.
How is Chonluten administered?
In research, Chonluten is usually administered subcutaneously or intranasally, depending on the desired delivery and model.
Can Chonluten be combined with other peptides?
Yes, researchers often stack Chonluten with peptides like Bronchogen, Semax, or B7-33 to enhance lung recovery and reduce inflammation.
Related Offers
Lab Tested
Domestic & International
NEW
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance GHK-Cu Copper tripeptide-1
Strength 50 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Copper-binding peptide
Peptide Sequence Gly-His-Lys Tripeptide
Copper Complex Cu2+
Human Half-Life Not established
$27.00
$45.00
Lab Tested
NEW
Shipped International
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance Examorelin Hexarelin
Strength 5 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class GH secretagogue
Peptide Length 6 amino acids Hexapeptide
Terminal Half-Life ~55 minutes
Primary Target GHS-R Ghrelin receptor pathway
$41.40
$69.00
Lab Tested
NEW
Shipped International
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance PE-22-28 Spadin-derived peptide
Strength 10 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Neuropeptide Spadin-derived analogue
Peptide Length 7 amino acids GVSWGLR
Human Half-Life Not established
Primary Target TREK-1 K2P potassium channel
$27.00
$45.00
NEW
Shipped International
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance Pinealon EDR peptide
Strength 20 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Peptide bioregulator
Peptide Sequence Glu-Asp-Arg EDR · Tripeptide
Human Half-Life Not established
Research Focus Neuroprotection Neuronal & cognitive research
$33.00
$55.00